Sort by
Refine Your Search
-
Listed
-
Field
-
, Ph.D. This position is designed to recruit two highly motivated postdocs with a strong background in molecular biology or virology to support studies on Epstein-Barr virus (EBV) oncology. Individuals
-
agreements on a temporary or permanent basis for any reason at any time. All required qualifications must be documented on application materials. Required Qualifications: • PhD in Retinal Biology, Immunology
-
biology, genetics, physiology or biomedicine and have a strong track record of, and potential for, success. The applicant should have a keen research interest in cell signaling, calcium dynamics
-
research experience in the following areas: 1) Stem cell biology 2) Spinal cord injury cell transplantation ● Experience with cell culture, microscopy and analysis, live cell imaging, and animal behavior
-
cytometry, nucleic acid extraction and quantification, western blotting, ELISA, and next generation sequencing is required. Proficiency with computers is essential as the use of office software, including
-
or related field; a strong publication record, and experience in any of the following areas: bacterial genetics, genomics, and metabolism. About the Department The Department of Plant and Microbial Biology
-
and manipulation of synaptic function, including novel multiphoton imaging, optogenetic, and computational tools. We are looking for a highly motivated individual with a strong background in cellular
-
of Minnesota, Twin Cities, are jointly seeking 1-2 highly motivated wet-lab Postdoctoral Associates. Our research is based at the Masonic Institute on the Biology of Aging and Metabolism (MIBAM), the Department
-
of Biochemistry, Molecular Biology and Biophysics is committed to understanding the molecular mechanisms of metabolic diseases and cancer; developing novel strategies in biocatalysis and biotechnology; and
-
• PhD, DDS, DVM, JD, MD or equivalent is required. Preferred Qualifications • Experience with primary airway epithelial cell biology. • Experience with viral vector-based gene therapy for pulmonary